Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinical pharmacology of non-sedating antihistamines
Kazuhiko Yanai, Takeo Yoshikawa, Ai Yanai, et al.
Pharmacology & Therapeutics (2017) Vol. 178, pp. 148-156
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Japanese guidelines for atopic dermatitis 2020
Norito Katoh, Yukihiro Ohya, Masanori Ikeda, et al.
Allergology International (2020) Vol. 69, Iss. 3, pp. 356-369
Open Access | Times Cited: 162
Molecular mechanism of antihistamines recognition and regulation of the histamine H1 receptor
Dandan Wang, Qiong Guo, Zhangsong Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
Hideyuki Kawauchi, Kazuhiko Yanai, De Yun Wang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 213-213
Open Access | Times Cited: 127
Clinical practice guidelines for the management of atopic dermatitis 2018
Norito Katoh, Yukihiro Ohya, Masanori Ikeda, et al.
The Journal of Dermatology (2019) Vol. 46, Iss. 12, pp. 1053-1101
Open Access | Times Cited: 115
Pharmacogenomics for the efficacy and side effects of antihistamines
Liqiao Li, Runqiu Liu, Cong Peng, et al.
Experimental Dermatology (2022) Vol. 31, Iss. 7, pp. 993-1004
Open Access | Times Cited: 51
Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity
Velid Ünsal, Erkan Öner, Reşit Yıldız, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness
Takeo Yoshikawa, Tadaho Nakamura, Kazuhiko Yanai
British Journal of Pharmacology (2020) Vol. 178, Iss. 4, pp. 750-769
Open Access | Times Cited: 60
Antihistamines in children and adolescents: A practical update
Giuseppe Fabio Parisi, Salvatore Leonardi, Giorgio Ciprandi, et al.
Allergologia et Immunopathologia (2020) Vol. 48, Iss. 6, pp. 753-762
Closed Access | Times Cited: 41
Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines
Jasmine Chang, Leila Cattelan, Moshe Ben‐Shoshan, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 187-199
Open Access | Times Cited: 33
Balanced discussion about bilastine as a truly non-sedating antihistamine
Amalia Leceta, Kazuhiko Yanai
Current Medical Research and Opinion (2025), pp. 1-6
Closed Access
Letter to the Editor: Author Response for “Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review”
Ignacio J. Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Current Medical Research and Opinion (2025), pp. 1-5
Closed Access
Rinitis alérgica
Victòria Cardona, Arnau Salvany-Pijuan, Javier Pereira-González
Medicina Clínica (2025) Vol. 164, Iss. 11, pp. 106916-106916
Closed Access
Drug-Induced Insomnia and Excessive Sleepiness
Ann Van Gastel
Sleep Medicine Clinics (2018) Vol. 13, Iss. 2, pp. 147-159
Closed Access | Times Cited: 44
The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor
Reggie Bosma, Jelle van den Bor, Henry F. Vischer, et al.
European Journal of Pharmacology (2018) Vol. 838, pp. 107-111
Open Access | Times Cited: 35
Chronic brain histamine depletion in adult mice induced depression-like behaviours and impaired sleep-wake cycle
Yo Yamada, Takeo Yoshikawa, Fumito Naganuma, et al.
Neuropharmacology (2020) Vol. 175, pp. 108179-108179
Closed Access | Times Cited: 29
Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades
Mengjie Sun, Di Qin, Pengsheng Fan, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 422-436
Closed Access | Times Cited: 26
Drug-Induced Insomnia and Excessive Sleepiness
Ann Van Gastel
Sleep Medicine Clinics (2022) Vol. 17, Iss. 3, pp. 471-484
Closed Access | Times Cited: 18
First-Generation Antihistamines and Seizures in Young Children
Ju Hee Kim, Eun Kyo Ha, Boeun Han, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2429654-e2429654
Open Access | Times Cited: 3
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson’s disease
Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, et al.
Journal of Neural Transmission (2017) Vol. 125, Iss. 9, pp. 1355-1360
Closed Access | Times Cited: 29
Oral histidine intake improves working memory through the activation of histaminergic nervous system in mice
Tadaho Nakamura, Fumito Naganuma, Uta Kudomi, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 609, pp. 141-148
Open Access | Times Cited: 15
Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation
Sang-Won Jeon, Jin‐Hyun Park, Joo-Eun Kim, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 3, pp. 407-416
Closed Access | Times Cited: 8
The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial
Yumi Kitahiro, Kazuhiro Yamamoto, Kimikazu Yakushijin, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e54882-e54882
Open Access | Times Cited: 2
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review
Ignacio J. Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1297-1309
Open Access | Times Cited: 2
Histamine and Delirium: Current Opinion
Paul L. Chazot, Laura Johnston, Edel Mcauley, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 17
Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine
Tadaho Nakamura, Kotaro Hiraoka, Ryuichi Harada, et al.
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 4
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top